Special reports Archives - Parkinson's Life

Special reports

More than 7300 male veterans took part in the study
READ MORE
Special reports

The study tested 411 people over a three year period
READ MORE
Special reports

A study has found a link between head injuries and Parkinson’s
READ MORE

Age, smoking and lack of fitness increase risk of Parkinson’s

More than 7300 male veterans took part in the study

Parkinson’s drugs may lead to compulsive behaviours such as gambling

The study tested 411 people over a three year period

A single head injury could increase risk of Parkinson’s

A study has found a link between head injuries and Parkinson’s

woman talking with business colleagues in office

STEP – The lived experience of Parkinson’s disease

STEP™ hopes to give a voice to people living with Parkinson’s

Crowded sidewalk on Oxford Street in London

Parkinson’s prevalence expected to increase by 18% in next seven years

Aging UK population could see increase in Parkinson’s over time

Neurological disorders – including Parkinson’s – are leading source of disability globally

Parkinson’s is world’s fastest growing neurological disorder

£16,000 a year: the hidden price of Parkinson’s

Research reveals the monetary cost of Parkinson’s for UK families

Muhammad Ali’s death “has raised Parkinson’s awareness”

Muhammad Ali’s legacy lives on

How close are we to a Parkinson’s breakthrough? Three experts have their say

Renowned experts give their opinions on the next breakthrough

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Latest findings from 100 for Parkinson’s study released

Paws for thought: dogs sniff out Parkinson’s disease with 90% hit rate

Dogs have been trained to sniff out Parkinson’s disease

High blood pressure, arthritis and depression are most common conditions in Parkinson’s patients

“We cannot gather too much data”

More than a third of Parkinson’s patients hide symptoms “out of fear or shame”

Parkinson’s patients “too afraid” to reveal diagnosis

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

President of APPDE calls PD REHAB trial “damaging”

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Second Life: a (virtual) world without Parkinson’s

Are we too focused on the search for a Parkinson’s cure?

We ask Parkinson’s experts for their views on this controversial debate

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

Shedding light on the dementia often mistaken for Parkinson’s

“Brain Surgery Live is a modern medical miracle the public deserved to see”

Exposure for such modern miracles is crucial, argues Justin Rossi

The future generation of advanced therapies for Parkinson’s

Dr Kieran Breen explores the potential of stem cell & gene therapies

Neurologists should be ‘guides not gods’ – Part 2

Top expert Bastiaan Bloem argues the case for a more holistic approach

Parkinson’s and depression: It’s not all in your mind

Depression may be common among PwPs, but it's not a sign of weakness

Neurologists should be ‘guides not gods’ – Part 1

Why physicians need to come down from their 'ivory towers'

Parkinson’s gene therapy could improve motor symptoms

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s. The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences. The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function. Professor Thomas Foltynie, neurology consultant at University College London Hospitals – which is carrying out the research alongside University College London – said: “Genes that increase the production of dopamine could help alleviate the symptoms of Parkinson’s disease, potentially with fewer side effects than traditional drug treatments, by targeting only the areas of the brain that are lacking in dopamine.”

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

Pharmaceutical company Pfizer has teamed with investment firm Bain Capital to launch Cerevel Therapeutics – a biopharmaceutical company focused on developing drugs for Parkinson’s and other central nervous system conditions. The new company – which will receive US $350 million of investment from Bain Capital – will begin working on phase three clinical trials on a Parkinson’s drug designed to increase levels of dopamine in the brain. Cerevel will also continue to develop several of Pfizer’s drug programmes which closed earlier this year. Marco Baptista, director of research programmes at The Michael J Fox Foundation – which has partnered with Pfizer since 2010 – said: “This is welcome news for Parkinson’s patients and researchers. Pfizer had developed a diverse group of novel therapeutics for Parkinson’s disease, which are now going to get another chance at success. MJFF looks forward to partnering with Cerevel to support the advancement of these promising…

AI technology could diagnose Parkinson’s in less than three minutes

Chinese technology enterprise Tencent has partnered with UK healthcare company Medopad and the Centre of Excellence in Parkinson’s and Movement Disorders at Kings College Hospital, UK, to create artificial intelligence (AI) software that may be able to diagnose Parkinson’s in less than three minutes. The team trained the AI system by analysing video footage of people with Parkinson’s, and believes it will help doctors identify and diagnose the condition at a far earlier stage. In addition, it is hoped the test could be carried out remotely using smartphone technology. Dan Vahdat, CEO and Co-founder of Medopad, said: “Our partnership with Tencent comes from a shared vision to change the future of healthcare as we know it. “In combining Medopad’s medical expertise and Tencent’s technical capabilities, we hope to provide the technology needed to support clinicians to predict preventable complications for people with Parkinson’s disease.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Age, smoking and lack of fitness increase risk of Parkinson’s

Parkinson’s drugs may lead to compulsive behaviours such as gambling

A single head injury could increase risk of Parkinson’s

Special reports

Special reports

Special reports

Age, smoking and lack of fitness increase risk of Parkinson’s

Parkinson’s drugs may lead to compulsive behaviours such as gambling

A single head injury could increase risk of Parkinson’s

sponsored article

STEP – The lived experience of Parkinson’s disease

Parkinson’s prevalence expected to increase by 18% in next seven years

Neurological disorders – including Parkinson’s – are leading source of disability globally

£16,000 a year: the hidden price of Parkinson’s

Muhammad Ali’s death “has raised Parkinson’s awareness”

How close are we to a Parkinson’s breakthrough? Three experts have their say

100 for Parkinson’s: patients suffer lower moods, higher stress levels and poorer sleep quality

Paws for thought: dogs sniff out Parkinson’s disease with 90% hit rate

High blood pressure, arthritis and depression are most common conditions in Parkinson’s patients

More than a third of Parkinson’s patients hide symptoms “out of fear or shame”

Why we should treat this ‘damaging’ study on physiotherapy in Parkinson’s with caution

How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life

Are we too focused on the search for a Parkinson’s cure?

Lewy body dementia: “The worst of Parkinson’s and Alzheimer’s together”

“Brain Surgery Live is a modern medical miracle the public deserved to see”

The future generation of advanced therapies for Parkinson’s

Neurologists should be ‘guides not gods’ – Part 2

Parkinson’s and depression: It’s not all in your mind

Neurologists should be ‘guides not gods’ – Part 1

{categories}

{title}

Parkinson’s gene therapy could improve motor symptoms

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

{title}

Subscribe

Sign in